201. Far-infrared rays enhance mitochondrial biogenesis andGLUT3expression under low glucose conditions in rat skeletal muscle cells
- Author
-
Ho Sung Lee, Sun-Woo Kim, Tong Zhou, Geonwoo Jang, Jung-Ha Kim, Young-Won Kim, Doegeun Hwang, Junhyeok Lee, Taewoo Kim, Hyoweon Bang, Jin Han, Wonyeong Jeong, Jung Soo Suh, Jae-Hong Ko, Hyoung Kyu Kim, Donghee Lee, Yerim Lee, Dong-Hyeon Kim, Kyoungseo Kim, Junho Choi, Changyeob Baek, and Yelim Seo
- Subjects
0301 basic medicine ,Pharmacology ,Membrane potential ,medicine.medical_specialty ,biology ,Physiology ,Chemistry ,Microarray analysis techniques ,Glucose transporter ,Skeletal muscle ,Carbohydrate metabolism ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,medicine.anatomical_structure ,Endocrinology ,Mitochondrial biogenesis ,Internal medicine ,Gene expression ,medicine ,biology.protein ,030217 neurology & neurosurgery ,GLUT3 - Abstract
Far-infrared rays (FIR) are known to have various effects on atoms and molecular structures within cells owing to their radiation and vibration frequencies. The present study examined the effects of FIR on gene expression related to glucose transport through microarray analysis in rat skeletal muscle cells, as well as on mitochondrial biogenesis, at high and low glucose conditions. FIR were emitted from a bio-active material coated fabric (BMCF). L6 cells were treated with 30% BMCF for 24 h in medium containing 25 or 5.5 mM glucose, and changes in the expression of glucose transporter genes were determined. The expression of GLUT3 (Slc2a3) increased 2.0-fold (p < 0.05) under 5.5 mM glucose and 30% BMCF. In addition, mitochondrial oxygen consumption and membrane potential (ΔΨm) increased 1.5- and 3.4-fold (p < 0.05 and p < 0.001), respectively, but no significant change in expression of Pgc-1a, a regulator of mitochondrial biogenesis, was observed in 24 h. To analyze the relationship between GLUT3 expression and mitochondrial biogenesis under FIR, GLUT3 was down-modulated by siRNA for 72 h. As a result, the ΔΨm of the GLUT3 siRNA-treated cells increased 3.0-fold (p < 0.001), whereas that of the control group increased 4.6-fold (p < 0.001). Moreover, Pgc-1a expression increased upon 30% BMCF treatment for 72 h; an effect that was more pronounced in the presence of GLUT3. These results suggest that FIR may hold therapeutic potential for improving glucose metabolism and mitochondrial function in metabolic diseases associated with insufficient glucose supply, such as type 2 diabetes.
- Published
- 2021
- Full Text
- View/download PDF